Affinergy, Inc. Signs Exclusive Development & License Agreement With Synthes, Inc.

Published: Sep 11, 2006

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Sept. 11, 2006--Affinergy, Inc., a Duke University spinout with a proprietary site-specific biological delivery system, announced that it has entered into a multi-year development & license agreement with Synthes. Affinergy will work exclusively with Synthes on multiple product applications across the Spine, Trauma and Craniomaxillofacial markets.

Back to news